Literature DB >> 16101685

Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy.

P Brown1.   

Abstract

Surprising advances have been made in the areas of blood infectivity, infectivity removal and, especially, blood screening tests for transmissible spongiform encephalopathy (TSE) in the past few years. In fact, if anyone as recently as last year had suggested that a screening test for preclinical human infection might be available before the end of 2005, the statement would have been met with smiling disbelief. Nevertheless, it can be confidently predicted that the diagnostic misfolded 'prion' protein (PrP(TSE)) will soon be reliably detectable in blood during the symptomatic phase of disease, and it is highly probable that it will also be detectable in blood from at least a proportion of infected individuals during the preclinical phase of disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101685     DOI: 10.1111/j.1423-0410.2005.00683.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  12 in total

1.  Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy.

Authors:  Angiola Rocino; Antonio Coppola; Massimo Franchini; Giancarlo Castaman; Cristina Santoro; Ezio Zanon; Elena Santagostino; Massimo Morfini
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

2.  Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake.

Authors:  Akihiko Urayama; Rodrigo Morales; Michael L Niehoff; William A Banks; Claudio Soto
Journal:  FASEB J       Date:  2011-05-09       Impact factor: 5.191

3.  Reduction of prion infectivity in packed red blood cells.

Authors:  Rodrigo Morales; Kimberley A Buytaert-Hoefen; Dennisse Gonzalez-Romero; Joaquin Castilla; Eric T Hansen; Dennis Hlavinka; Raymond P Goodrich; Claudio Soto
Journal:  Biochem Biophys Res Commun       Date:  2008-10-11       Impact factor: 3.575

Review 4.  Aptamers against prion proteins and prions.

Authors:  Sabine Gilch; Hermann M Schätzl
Journal:  Cell Mol Life Sci       Date:  2009-04-25       Impact factor: 9.261

Review 5.  Identification of misfolded proteins in body fluids for the diagnosis of prion diseases.

Authors:  Francesca Properzi; Maurizio Pocchiari
Journal:  Int J Cell Biol       Date:  2013-08-21

6.  Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Ed M Choi; Michael D Geschwind; Camille Deering; Kristen Pomeroy; Amy Kuo; Bruce L Miller; Jiri G Safar; Stanley B Prusiner
Journal:  Lab Invest       Date:  2009-06       Impact factor: 5.662

7.  Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.

Authors:  Graham S Jackson; Jesse Burk-Rafel; Julie Ann Edgeworth; Anita Sicilia; Sabah Abdilahi; Justine Korteweg; Jonathan Mackey; Claire Thomas; Guosu Wang; Jonathan M Schott; Catherine Mummery; Patrick F Chinnery; Simon Mead; John Collinge
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

8.  Application of Atomic Dielectric Resonance Spectroscopy for the screening of blood samples from patients with clinical variant and sporadic CJD.

Authors:  Timothy J Fagge; G Robin Barclay; G Colin Stove; Gordon Stove; Michael J Robinson; Mark W Head; James W Ironside; Marc L Turner
Journal:  J Transl Med       Date:  2007-08-30       Impact factor: 5.531

Review 9.  Silent Prions and Covert Prion Transmission.

Authors:  Candace K Mathiason
Journal:  PLoS Pathog       Date:  2015-12-10       Impact factor: 6.823

10.  Re-assessment of PrP(Sc) distribution in sporadic and variant CJD.

Authors:  Richard Rubenstein; Binggong Chang
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.